Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Accenture
Johnson and Johnson
Fuji
Boehringer Ingelheim
Julphar
Merck
McKesson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Drugs with Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

« Back to Dashboard

Drugs with Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-001 Apr 10, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial TABLET, ORALLY DISINTEGRATING;ORAL
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-002 Apr 10, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial TABLET, ORALLY DISINTEGRATING;ORAL
Mylan Pharms Inc PREDNISOLONE SODIUM PHOSPHATE prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 202179-003 Apr 10, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial TABLET, ORALLY DISINTEGRATING;ORAL
Sun Pharm Inds Ltd LORATADINE REDIDOSE loratadine TABLET, ORALLY DISINTEGRATING;ORAL 077153-001 Apr 11, 2007 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial TABLET, ORALLY DISINTEGRATING;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Farmers Insurance
AstraZeneca
Boehringer Ingelheim
Covington
Cantor Fitzgerald
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.